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abstract
 
We used the patch-clamp technique to study the effect of arachidonic acid (AA) on epithelial Na
channels (ENaC) in the rat cortical collecting duct (CCD). Application of 10 
 
 
 
M AA decreased the ENaC activity
deﬁned by NPo from 1.0 to 0.1. The dose–response curve of the AA effect on ENaC shows that 2 
 
 
 
M AA inhibited
the ENaC activity by 50%. The effect of AA on ENaC is speciﬁc because neither 5,8,11,14-eicosatetraynoic acid
(ETYA), a nonmetabolized analogue of AA, nor 11,14,17-eicosatrienoic acid mimicked the inhibitory effect of
AA on ENaC. Moreover, inhibition of either cyclooxygenase (COX) with indomethacin or cytochrome P450
(CYP) 
 
 
 
-hydroxylation with 
 
N
 
-methylsulfonyl-12,12-dibromododec-11-enamide (DDMS) failed to abolish the effect
of AA on ENaC. In contrast, the inhibitory effect of AA on ENaC was absent in the presence of 
 
N
 
-methylsulfonyl-6-
(propargyloxyphenyl)hexanamide (MS-PPOH), an agent that inhibits CYP-epoxygenase activity. The notion
that the inhibitory effect of AA is mediated by CYP-epoxygenase–dependent metabolites is also supported by the
observation that application of 200 nM 11,12-epoxyeicosatrienoic acid (EET) inhibited ENaC in the CCD. In
contrast, addition of 5,6-, 8,9-, or 14,15-EET failed to decrease ENaC activity. Also, application of 11,12-EET
can still reduce ENaC activity in the presence of MS-PPOH, suggesting that 11,12-EET is a mediator for the
AA-induced inhibition of ENaC. Furthermore, gas chromatography mass spectrometry analysis detected the
presence of 11,12-EET in the CCD and CYP2C23 is expressed in the principal cells of the CCD. We conclude that
AA inhibits ENaC activity in the CCD and that the effect of AA is mediated by a CYP-epoxygenase–dependent
metabolite, 11,12-EET.
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INTRODUCTION
 
Maintaining Na homeostasis is essential for the regula-
tion of blood pressure (Verrey et al., 2000). The kidney
plays an important role in maintaining the extracellular
Na in the normal range (Koeppen and Stanton, 1992)
and the cortical collecting duct (CCD) is responsible
for the hormone-regulated Na absorption. Na absorption
in the CCD takes place by a two-step process: Na enters
the cells across the apical membrane via ENaC (epithelial
Na channel) and is extruded from the cell across the
basolateral membrane through Na-K-ATPase. It is well
established that the rate-limiting step for Na absorption
in the CCD is the apical Na conductance (Koeppen
and Stanton, 1992), which is regulated by aldosterone
and Na intake; a high aldosterone level augments,
whereas an increased Na intake decreases, apical ENaC
channel activity. Moreover, it has been demonstrated
that the early effect of aldosterone on ENaC is to
stimulate the channel open probability (Kemendy et
al., 1992), whereas the late effect of aldosterone (
 
 
 
1 h)
is to increase the ENaC number in the apical membrane
(Pácha et al., 1993). Although decreases in plasma
aldosterone levels play a role in suppressing renal Na
transport induced by high Na intake (Verrey et al.,
2000), it is possible that factors other than aldosterone
may also be involved in the inhibition of renal Na trans-
port by high Na intake. Relevant to this hypothesis is
the observation that high Na intake increases cytochrome
P450 (CYP)-epoxygenase–dependent arachidonic acid
(AA) metabolites such as 11,12-epoxyeicosatrienoic acid
(EET) (Makita et al., 1994). This suggests that AA and
its metabolites may be involved in the regulation of Na
transport in the CCD. In this regard, it has been re-
ported that 5,6-EET inhibits Na transport in the rab-
bit CCD (Sakairi et al., 1995). AA has also been shown
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to block the apical 35 pS K channel in the apical mem-
brane of the CCD, however, it is not clear whether AA
can also regulate the ENaC activity. Therefore, the
present study is designed to examine the effect of AA
on ENaC and to determine the metabolite responsible
for the effect of AA on ENaC.
 
MATERIALS AND METHODS
 
Preparation of CCDs
 
Pathogen-free Sprague-Dawley rats of either sex (5–6 wk) were
used in the experiments and purchased from Taconic Farms, Inc.
Rats were maintained on a Na-deﬁcient diet for 5–7 d and killed
by cervical dislocation. Kidneys were removed immediately and
several thin slices of the kidney (
 
 
 
1 mm) were cut. The kidney
slices were placed on an ice-cold Ringer solution and the CCD
was isolated with watch-make forceps. The isolated CCD was
placed on a 5 
 
 
 
 5 mm coverglass coated with polylysine and the
coverglass was transferred to a chamber (1,000 
 
 
 
l) mounted on
an inverted Nikon microscope. The CCDs were superfused with
HEPES-buffered NaCl solution, and the temperature of the
chamber was maintained at 37 
 
 
 
 1
 
 
 
C by circulating warm water
surrounding the chamber. The CCD was cut open with a sharp-
ened micropipette to expose the apical membrane. For the mea-
surement of 11,12-EET, both kidneys were perfused with 0.5%
collagenase-containing ringer to wash out the blood. The kidney
slices were incubated with the 0.5% collagenase-containing
Ringer for an additional 3–5 min before dissection.
 
Patch-clamp Technique
 
An Axon200A patch-clamp ampliﬁer was used to record channel
current that was low-pass ﬁltered at 50 Hz by an eight pole Bessel
ﬁlter (902LPF; Frequency Devices). The Na current was re-
corded and digitized by an Axon Instruments, Inc. interface
(Digidata 1200). Data were analyzed using the pClamp software
system 7.0 (Axon Instruments, Inc.). Channel activity deﬁned as
NP
 
o
 
 was calculated from data samples of 60 s duration in the
steady state as follows:
 
(1)
 
where t
 
i
 
 was the fractional open time spent at each of the ob-
served current levels. The channel conductance was calculated
by recording the current at least three holding potentials.
 
Measurement of EET
 
The CCDs were isolated and placed in a tube containing ice-cold
Na Ringer (0.5 ml). Eicosanoids in the CCD and media were
acidiﬁed to pH 4.0 with 9% formic acid. After addition of 2 ng of
D
 
8
 
 11,12-EET as internal standard, the samples were extracted
twice with 2
 
 
 
 volume ethyl acetate and evaporated to dryness.
After extraction, the tubules were homogenized and the protein
concentration was measured. The samples were puriﬁed by re-
verse phase (RP)-HPLC on a C
 
18
 
 
 
 
 
Bondapak column (4.6 
 
 
 
 24
mm) using a linear gradient from acetonitrile:water:acetic acid
(62.5:37.5:0.05%) to acetonitrile (100%) over 20 min at a ﬂow
rate of 1 ml/min. The fraction containing 11,12-EET was col-
lected on the basis of the elution proﬁle of standards monitored
by ultraviolet absorbance (205 nm). The fractions were evapo-
rated to dryness and resuspended in 100 
 
 
 
l of acetonitrile. HPLC
fractions containing 11,12-EET were derivatized as described ear-
lier (Croft et al., 2000). The derivatized 11,12-EET was dried with
nitrogen and resuspended in 50 
 
 
 
l of iso-octane for gas chroma-
tography mass spectrometry analyses. A 1-
 
 
 
l aliquot of deriva-
tized CYP-derived AA metabolites, dissolved in iso-octane, was in-
jected into a GC (Hewlett Packard 5890) column (DB-1ms; 10.0 m,
0.25 mm inner diameter, 0.25 
 
 
 
m ﬁlm thickness; Agilent). We
used temperature programs ranging from 150 to 300
 
 
 
C at rates
of 25
 
 
 
C/min, respectively (Macica et al., 1993). Methane was
used as a reagent gas at a ﬂow resulting in a source pressure of
1.3 torr and the MS (Hewlett-Packard 5989A) was operated in
NPo t1 2t2 …iti ++ () ∑ , =
Figure 1. A channel recording showing the channel activity of
ENaC under control conditions (without amiloride) (A) and in
the presence of 0.5  M amiloride (B). The channel closed level is
indicated by “C” and the holding potential was indicated on the
top of the corresponding trace.
Figure 2. A channel recording showing the effect of AA on ENaC
in a cell-attached patch. The channel closed level is indicated
by “C” and a dotted line. The holding potential was  40 mV
(hyperpolarization). 
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electron capture chemical ionization mode. The endogenous
11,12-EET (ion 
 
m/z
 
 319) was identiﬁed by comparison of GC re-
tention times with authentic D
 
8
 
 11,12-EET (
 
m/z
 
 327) standards.
 
Immunocytochemical Staining
 
Sprague-Dawley rats (6 wk) were anesthetized with isoﬂurane
and the abdomen was cut open for perfusion of kidneys with 50
ml PBS containing heparin (40 unit/ml) followed by 200 ml of
4% paraformaldehyde. After perfusion, the kidneys were re-
moved and subjected to post-ﬁxation with 4% paraformaldehyde
for 12 h. The kidneys were dehydrated and cut to 8–10 
 
 
 
M slices
by Leica1900 cryostat (Leica). The tissue slices were dried at
42
 
 
 
C for 1 h. The slides were washed with 1
 
 
 
 PBS for 15 min,
and permeabilized with 0.4% Triton dissolved in 1
 
 
 
 PBS buffer
containing 1% BSA and 0.1% lysine (pH 7.4) for 15 min. Kidney
slices were blocked with 2% goat serum for 1 h at room tempera-
ture and then incubated with aquaporin 2 (AQP2) (Alomone)
and CYP2C23 (a gift from J. Capdevila, Vanderbilt University,
Nashville, TN) for 12 h at 4
 
 
 
C. Slides were thoroughly washed
with 1
 
 
 
 PBS followed by incubation in second antibody mixtures
in 0.4% Triton dissolved in 1
 
 
 
 PBS for 2 h at room temperature.
 
Solution and Statistics
 
The bath solution contains (in mM) 140 NaCl, 5 KCl, 1.8 CaCl
 
2
 
,
1.8 MgCl
 
2
 
, and 10 HEPES (pH 7.4). The pipette solution was com-
posed of (in mM) 135 NaCl, 5 KCl, 1.8 Mg
 
2
 
Cl, and 5 HEPES (pH
7.4). Indomethacin was purchased from Sigma-Aldrich whereas
5,8,11,14-eicosatetraynoic acid (ETYA) and EETs were obtained
from Biomol. AA and 11,14,17-eicosatrienoic acid were obtained
from Nu-Check. 
 
N
 
-methylsulfonyl-12,12-dibromododec-11-enamide
(DDMS) and 
 
N
 
-methylsulfonyl-6-(propargyloxyphenyl)hexanamide
(MS-PPOH) were synthesized in Dr. Falck’s laboratory, Southwest-
ern Medical Center at Dallas. DDMS and MS-PPOH are AA ana-
logs which inhibit CYP-dependent 
 
 
 
-hydroxylation and CYP-
epoxygenase, respectively (Wang et al., 1998). The data is pre-
sented as mean 
 
  
 
SEM. We used paired and unpaired Student’s
 
t-
 
test to determine the statistical signiﬁcance. If the P value was less
than 0.05, the difference was considered to be signiﬁcant.
 
RESULTS
 
AA Inhibits ENaC
 
We used the patch-clamp technique to study the effect
of AA on ENaC in the isolated CCD from rats on a Na-
deﬁcient diet (
 
 
 
0.001%) for 5–7 d because ENaC activ-
ity is very difﬁcult to detect in the CCD from rats on a
normal Na diet (0.5%). Fig. 1 A is a recording showing
ENaC activity in a cell-attached patch at 
 
 
 
60, 
 
 
 
40, and
 
 
 
20 mV (hyperpolarization), respectively. The channel
slope conductance is 5.5 
 
 
 
 0.5 pS between 
 
 
 
80 and
 
 
 
20 mV. Fig. 1 B shows the channel activity in the pres-
ence of 0.5 
 
 
 
M amiloride in the pipette solution. It is
apparent that the channel activity is ﬂickery, an indica-
tion of amiloride-mediated blockade. To study the ef-
fect of AA on ENaC, we recorded the channel activity
under control conditions for 3–5 min. When Na chan-
nel activity reached a steady state, AA was applied to the
bath media while the channel activity was continuously
monitored. The effect of AA can be observed in 5 min
approximately and it reaches the steady state in 10–15
min. Thus, we have selected a 60-s-long record in the
steady state between 10–15 min after AA to calculate
NP
 
o
 
. Fig. 2 is a recording showing that application of 10
 
 
 
M AA inhibited ENaC and reduced NP
 
o
 
 from 1.0 
 
 
 
0.2 to 0.1 
 
 
 
 0.03 (
 
n
 
 
 
  
 
10). The effect of AA was revers-
ible because washout of AA restored the channel activ-
ity (unpublished data). Since the experiments were
performed in the split-open tubule, it is not possible to
determine the sidedness of AA effect.
After establishing that AA inhibits ENaC, we studied
the dose response curve of AA effect on ENaC in the
CCD. Fig. 3 is a dose–response curve of the AA effect
on ENaC and K
 
d
 
, a concentration that is required to in-
hibit the channel activity by 50%, is 
 
 
 
2 
 
 
 
M.
To determine whether the effect of AA is the result of
changing membrane ﬂuidity that could affect channel
activity (Meves, 1994; Petrou et al., 1994), we also ex-
amined the effect on ENaC of ETYA, a nonmetaboliz-
able AA analogue, and 11,14,17-eicosatrienoic acid
(EA), an unsaturated fatty acid. We followed the proto-
col of AA experiments and examined the ENaC activity
in the continuous presence of ETYA or EA for at least
10 min. Data summarized in Fig. 4 show that applica-
tion of ETYA (10 
 
 
 
M) (control NP
 
o
 
, 1.2 
 
 
 
 0.2; ETYA,
1.0 
 
 
 
 0.1) (
 
n
 
 
 
  
 
5) and 10 
 
 
 
M EA failed to inhibit the
activity of ENaC (control NP
 
o
 
, 1.1 
 
 
 
 0.2, EA, 1.1 
 
 
 
 0.2)
(
 
n
 
 
 
  
 
5). This indicates that the inhibitory effect of AA
on ENaC is not the result of altering the membrane
physical properties.
Figure 3. A dose–response curve of AA effect on ENaC. Each
point represents a mean value from 3–10 patches.
Figure 4. Effect of 10  M ETYA, 11,14,17-EA, and AA on ENaC
activity. The experiments were performed in cell-attached patches. 
722
 
AA Inhibits ENaC
 
The Inhibitory Effect of AA Is Mediated by CYP-epoxygenase–
dependent Pathway
 
After demonstrating that AA inhibited ENaC in the
CCD, we examined whether the effect of AA on ENaC
was mediated by AA per se or AA metabolites. Thus, we
extended the study by examining the effect of AA on
ENaC in the presence of speciﬁc inhibitors of AA
metabolic enzymes. It is well established that AA can
be metabolized by cyclooxygenase (COX)-dependent
pathway in the renal tubules. To test the possibility that
AA inhibits ENaC by COX-dependent AA metabolites,
we examined the effect of AA in the presence of in-
domethacin, an inhibitor of COX. Application of 5 
 
 
 
M
indomethacin had no effect on ENaC activity (control
NP
 
o
 
, 1.1 
 
 
 
 0.1; indomethacin, 1.23 
 
 
 
 0.1) (
 
n
 
 
 
  
 
6) (Fig.
5). Moreover, inhibition of COX failed to abolish the
AA-induced inhibition on ENaC. Data summarized in
Fig. 5 show that in the presence of indomethacin, ap-
plication of AA still inhibited the ENaC activity (NP
 
o
 
,
0.14 
 
 
 
 0.1) (
 
n   6). This indicates that the effect of AA
on ENaC was not mediated by COX-dependent metab-
olites. Also, we investigated the effect of AA on ENaC in
the presence of inhibitors of CYP monooxygenases,
which have been shown to be expressed in the kidney
(McGiff, 1991). First, we tested whether inhibition of
CYP  -hydroxylase could abolish the inhibitory effect
of AA on ENaC. We have previously shown that AA
is converted to 20-hydroxyeicosatetraenoic acid (20-
HETE) by CYP-dependent  -hydroxylation and that 20-
HETE inhibits the apical 70 pS K channel in the TAL
(Wang and Lu, 1995). Therefore, we examined the ef-
fect of AA on ENaC in the presence of DDMS, an inhib-
itor of CYP-dependent  -hydroxylation (Wang et al.,
1998). Inhibition of CYP hydroxylases did not signiﬁ-
cantly alter the channel activity (control NPo, 1.1   0.1;
DDMS, 1.45   0.2) (n   10). Also, AA can still inhibit
the channel activity in the presence of DDMS. Fig. 6 is a
recording showing that DDMS failed to abolish the in-
hibitory effect of AA on ENaC and that 10  M AA re-
duced NPo from 1.45   0.2 to 0.3   0.05 (n   10).
After excluding the role of CYP-dependent hydroxyl-
ation in mediating the effect of AA on ENaC, we exam-
ined the effect of AA on ENaC in the presence of MS-
PPOH, an inhibitor of CYP-epoxygenase (Wang et al.,
1998). Blocking CYP-epoxygenase not only signiﬁcantly
increased ENaC activity from 1.06   0.12 to 1.65   0.25
(n   11) but also abolished the effect of AA on ENaC.
Fig. 7 is a representative recording demonstrating that
inhibition of CYP-epoxygenase abolished the effect of
AA on ENaC because NPo in the presence of AA was
1.5   0.2, which is not signiﬁcantly different from that
without AA.
11,12-EET Inhibits ENaC 
After determining that the inhibitory effect of AA on
ENaC is mediated by the epoxygenase-dependent path-
way, we investigated the effect of 11,12-EET on ENaC
because 11,12-EET accounts for 60% of the total EET
Figure 5. The effect of 10  M AA in the presence 5  M in-
domethacin (Indo), 15  M MS-PPOH (PPOH), and 5  M DDMS.
The experiments were performed in cell-attached patches and
asterisk indicates that the data is signiﬁcantly different from the
corresponding control value.
Figure 6. A channel recording showing the effect of 10  M
AA on ENaC in the presence DDMS. The channel closed level is
indicated by a dotted line.
Figure 7. A channel recording showing the effect of 10  M AA
on ENaC in the presence of MS-PPOH. The channel closed level is
indicated by a dotted line.723 Wei et al.
in the kidney (Holla et al., 1999). Fig. 8 is a channel re-
cording made in a cell-attached patch. It is apparent
that application of 200 nM 11,12-EET mimicked the ef-
fect of AA and inhibited the activity of ENaC. Data sum-
marized in Fig. 9 demonstrate that 200 nM 11,12-EET
reduced NPo from 1.2   0.12 to 0.2   0.05 (n   9). In
contrast, addition of 200 nM 20-HETE did not block
the ENaC activity (Fig. 9) and NPo was not changed be-
fore (1.05   0.1) and after 20-HETE (1.0   0.1). This
strongly suggests that CYP-epoxygenase plays a role in
the regulation of ENaC in the CCD. To test whether the
effect of 11,12-EET on ENaC could be mimicked by
other EETs such as 5,6-EET, we examined the effects of
5,6-EET, 8,9-EET, and 14,15-EET on ENaC in the CCD.
Data summarized in Fig. 9 demonstrated that applica-
tion of 200 nM 5, 6-EET (control NPo, 1.3   0.17; EET,
1.0   0.18) (n   5), 8,9-EET (control NPo, 1.4   0.19;
EET, 1.04   0.2) (n   5), or 14,15-EET (control NPo,
0.92   0.17; EET, 0.77   0.2) (n   5) did not signiﬁ-
cantly decrease the ENaC activity.
The view that 11,12-EET is responsible for the AA-
induced inhibition of ENaC is further supported by the
observation that the inhibitory effect of 11,12-EET on
ENaC was also observed in the presence of MS-PPOH
(Fig. 10) and decreased NPo from 1.1   0.1 to 0.12  
0.03 (n   6).
EET Is Present and CYP2C23 Is Expressed in the CCD
After demonstrating that AA inhibits ENaC and that
this effect of AA can be mimicked by 11,12-EET, we ex-
amined whether 11,12-EET is present in the CCD. The
CCDs were isolated and 11,12-EET extracted from the
CCDs was measured by GCMS. Fig. 11 is a histogram
showing that 11,12-EET is present in the isolated CCD
and the mean value from four measurements was 3.06  
0.3 ng/mg protein. Because CYP2C23 is the principal
isoform of CYP-epoxygenase responsible for converting
AA to 11,12-EET (Muller et al., 2004), we examined
whether CYP2C23 is expressed in the CCD using confo-
cal microscope. Fig. 12 is a typical confocal image show-
ing that CYP2C23 is expressed in the AQP2-positive
cells in the CCD. This conﬁrms that CYP2C23 is present
in principal cells of the CCD.
DISCUSSION
In the present study, we have demonstrated that AA in-
hibits ENaC in the CCD. Two lines of evidence indicate
that the inhibitory effect of AA is not the result of
changing membrane ﬂuidity: (1) neither ETYA nor
11,14,17-eicosatrienoic acid had a signiﬁcant effect on
ENaC; and (2) the effect of AA on ENaC was absent
in the presence of MS-PPOH, an inhibitor of CYP-
epoxygenase.
AA at high concentrations (50  M) has been shown
to inhibit the ENaC activity in Xenopus oocytes express-
ing three ENaC subunits ( ,  , and  ) and the effect of
AA is the result of stimulating the endocytosis of ENaC
(Carattino et al., 2003). Two lines of evidence suggest
that 50  M AA-induced inhibition of ENaC is not the
result of stimulating CYP-epoxygenase–dependent AA
Figure 8. A channel recording showing the effect of 200 nM
11,12 EET on ENaC. The experiment was performed in a cell-
attached patch and the channel closed level is indicated by a
dotted line.
Figure 9. The effect of 200 nM 5,6-, 8,9-, 11,12-, 14,15-EET and
20-HETE on ENaC. The asterisk indicates that the difference is
signiﬁcant from the corresponding control value. Experiments
were performed in cell-attached patches.
Figure 10. A channel recording showing the effect of 200 nM
11,12-EET on ENaC in the presence MS-PPOH. The channel
closed level is indicated by a dotted line and the experiment was
conducted in a cell-attached patch.724 AA Inhibits ENaC
metabolism. First, ETYA, a nonmetabolizable AA ana-
logue, mimicked the effect of 50  M AA on ENaC activ-
ity in oocytes. In contrast, application of ETYA failed to
inhibit ENaC activity in the CCD. Also, the ﬁnding that
blockade of CYP-epoxygenase abolished the effect of
AA of ENaC activity in the CCD indicates that the in-
hibitory effect of AA is mediated by CYP-epoxygenase
AA metabolites. Second, no signiﬁcant CYP-epoxygen-
ase activity can be detected in oocytes and cultured cell
lines (unpublished data). Thus, it is possible that AA at
physiological concentrations inhibits ENaC via a CYP-
epoxygenase–dependent pathway, whereas at high con-
centrations it decreases the ENaC activity by AA-medi-
ated endocytosis. Also, it is very likely that ETYA at high
concentrations or for a prolonged incubation may in-
hibit ENaC by a mechanism other than EET.
The observation that ETYA cannot mimic the effect
of AA suggests that the effect of AA is mediated by AA
metabolites. The major enzymes responsible for AA
metabolism in the kidney include COX, lipoxygenase,
and CYP monooxygenase (Roman, 2004). Moreover, a
large body of evidence indicates that both COX-depen-
dent and CYP enzyme–dependent metabolites of AA
play an important role in the regulation of membrane
transport in the kidney (Escalante et al., 1991; Ma et al.,
1994; Wang et al., 1996; Roman, 2004). The main me-
tabolites of a COX-dependent pathway of AA are pros-
taglandins such as PGE2, which have been shown to in-
hibit the transepithelial Cl transport (Culpepper and
Andreoli, 1983), bicarbonate transport (Good, 1996),
apical 70 pS K channels in the TAL (Liu et al., 2000),
and Na transport in the rabbit collecting tubule (Stokes
and Kokko, 1977). Moreover, PGE2 has been shown
to suppress the vasopressin-induced increase in water
channels (Hébert et al., 1990; Hebert et al., 1991). How-
ever, the observation that inhibition of COX did not
abolish the AA-induced inhibition of ENaC excluded
the role of the COX-dependent AA metabolite in
mediating the effect of AA. Also, it is unlikely that
11,12-EET–induced inhibition of ENaC required the
involvement of COX because 11,12-EET cannot be me-
tabolized by COX.
AA can be metabolized by CYP-dependent  -hydroxy-
lases and the main products are HETE derivatives such
as 19- or 20-HETE (Roman, 2004). 20-HETE has been
demonstrated to inhibit Na/Cl/K cotransporter and
the apical 70 pS K channel in the TAL (Escalante et al.,
1991; Wang and Lu, 1995). However, it is unlikely that
the effect of AA is mediated by the CYP-dependent
 -hydroxylases because DDMS did not block the effect
of AA on ENaC. Also, we observed that application of
20-HETE had no effect on ENaC.
Four lines of evidence indicate that the effect of AA is
mediated by 11,12-EET: (1) inhibition of CYP-epoxyge-
nase abolishes the effect of AA on ENaC; (2) addition
of 11,12-EET, but not other EETs, mimics the effect of
AA and inhibited ENaC; (3) 11,12-EET blocks the
ENaC in the presence of a CYP-epoxygenase inhibitor;
Figure 11. A histogram showing the presence of 11,12-EET in
the isolated CCD (top). The standard of 11,12-EET is shown on
the bottom of the ﬁgure.
Figure 12. Confocal images showing the CYP2C23
(green) and AQP2 (red) staining in the renal cortex.
The bar represents 10  M.725 Wei et al.
(4) 11,12-EET is present in the CCD. The role of EET
in the regulation of ion channels is well established.
EET has been shown to inhibit cardiac L-type Ca2 
channels (Chen et al., 1999a) and activate the Ca2 -
dependent large conductance K channels in smooth
muscle cells of renal vessels (Zou et al., 1996).
Although several CYP epoxygenases, such as CYP2C11,
2C12, 2C23, and 2C24, have been shown to be ex-
pressed in the renal tubules and are capable of con-
verting AA to EET (Roman, 2004), the CYP2C23 family
has been considered to be the major isoform in the
kidney to generate EET. Our unpublished observation
has indicated that CYP2C23 is expressed in the CCD.
Moreover, 11,12-EET accounts for over 60% of the total
renal EET (Holla et al., 1999). EET has been shown
to regulate Na transport in the CCD. For instance,
5,6-EET inhibits the Na/H exchanger via a Ca2 -depen-
dent pathway in the rabbit CCD (Sakairi et al., 1995).
However, the effect of 5,6-EET on the Na/H ex-
changer in the CCD is mediated by a COX-dependent
pathway because indomethacin abolished the effect of
5,6-EET.
The mechanism by which 11,12-EET inhibits ENaC is
not clear. We were not able to test the effect of either
AA or 11,12-EET on ENaC in inside-out patches be-
cause the channel activity ran down progressively. There-
fore, it is not known whether the effect of 11,12-EET
on ENaC results from direct blockade of ENaC or is
due to modulating protein kinases or phosphatases.
ENaC has been shown to be stimulated by PKA and
PTK and inhibited by PKC (Marunaka and Eaton,
1991; Ling et al., 1992; Matsumoto et al., 1993; Frindt
and Palmer, 1996; Frindt et al., 1996). On the other
hand, a large body of evidence has demonstrated that
AA and EET modulate a variety of signal transduction
pathways (Buckley and Whorton, 1995; Firsov et al.,
1995; Chen et al., 1999b; Spector et al., 2003; Cheng et
al., 2004). It has been reported that AA inhibits cAMP
formation induced by vasopressin in the TAL (Firsov et
al., 1995), whereas it stimulates tyrosine phosphoryla-
tion (Buckley and Whorton, 1995). EET has been
shown to diminish the effect of vasopressin on water
permeability in the CCD, presumably by decreasing
cAMP formation (Hirt et al., 1989). Also, 14,15-EET
has been demonstrated to activate PTK-dependent sig-
naling (Chen et al., 1999b). Thus, it is possible that the
effect of EET on ENaC may be partially mediated by
regulation of kinase activity. Further experiments are
required to test this hypothesis.
The physiological importance of the present ﬁnding
is that 11.12-EET may play an important role in the reg-
ulation of renal Na transport. The rate limiting step of
transepithelial Na transport in the CCD is the apical Na
conductance (Koeppen and Stanton, 1992), which is
determined by the number of Na channels in the apical
membrane and the channel open probability. Increases
in either Na channel numbers or channel open proba-
bility should augment the apical Na conductance and
lead to stimulation of Na absorption. For instance, Lid-
dle’s syndrome, an inherited form of hypertension, is
the result of decreasing endocytosis of ENaC and ac-
cordingly increasing the apical ENaC numbers in the
CCD (Shimkets et al., 1994; Snyder et al., 1995). Al-
though two types of Na channels, 4-6 pS and 28 pS,
have been identiﬁed in the collecting duct (Palmer and
Frindt, 1986; Light et al., 1988), it is generally accepted
that the 4-6 pS ENaC is mainly responsible for the Na
entry across the apical membrane in the CCD (Garty
and Palmer, 1997). Therefore, the present ﬁnding sug-
gests that AA and its metabolites play a role in the regu-
lation of apical Na conductance and Na transport in
the CCD.
Aldosterone is the main hormone regulating the
ENaC activity; a high plasma aldosterone increases,
whereas low aldosterone decreases, the apical ENaC
activity (Koeppen and Stanton, 1992). Moreover, the
early effect of aldosterone is to increase the ENaC open
probability, whereas the late effect is produced by in-
creasing the ENaC number in the apical membrane of
the CCD. In addition, Na diet also plays an important
role in the regulation of ENaC activity; low Na intake
increases the apical ENaC number (Palmer et al., 1994)
and the effect of low Na on ENaC is mediated by aldos-
terone. High Na intake decreases the apical ENaC
number and the effect of high Na intake on ENaC ac-
tivity is generally considered to be the result of decreas-
ing aldosterone levels. However, the observation that
high Na intake signiﬁcantly increases renal EET forma-
tion suggests that EET may also be responsible for de-
creasing ENaC activity induced by high Na intake. In
this regard, it has been shown that inhibition of CYP-
Figure 13. A schema illus-
trating the mechanism by
which high Na intake sup-
presses ENaC activity.726 AA Inhibits ENaC
epoxygenase AA metabolism causes hypertension in
rats on a high Na diet and that removal of an epoxygen-
ase inhibitor decreases the blood pressure in rats main-
tained on a high Na diet (Makita et al., 1994). Fig. 13 is
a schema illustrating the possible role of 11,12-EET in
the regulation of Na transport in the CCD. We specu-
late that a high Na intake stimulates the activity of CYP-
epoxygenase and increases the 11,12-EET levels, which
in turn inhibit ENaC and suppress Na transport in the
CCD. We conclude that AA inhibits ENaC activity
via CYP-epoxygenase AA metabolic pathway and that
11,12-EET mediates the inhibitory effect of AA on
ENaC in the CCD.
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